baber/WOPTO huggingface dataset:
Patent BR-PI1007570-B1 (BR)
Title: estator de máquina elétrica e método para enrolamento de um estator
Inventor: PIETRO DE FILIPPIS
IPC: H02K3/52
Filed: 2010-05-25
Abstract: Máquina elétrica e método para a sua fabricação. É descrito um método para construir uma máquina elétrica rotativa, compreendendo as etapas de: preparar um núcleo (18) tendo uma pluralidade de expansões de pólos e uma pluralidade de enrolamentos (100, 200, 300), feitos de material eletricamente condutivo nas expansões de pólos, onde pelo menos uma parte dos enrolamentos (100, 200, 300) é feita de um fio condutor com uma extremidade livre (14) que pode ser conectada eletricamente a uma fonte de alimentação de energia principal; acoplar de maneira estável, entre si, pelo menos duas extremidades livres (14) de enrolamentos diferentes (100, 200, 300), de modo a conectá-las a um único terminal de alimentação de energia; torcer as extremidades (14) acopladas para formar uma única terminação elétrica (5, 6, 7) torcida, ao longo de uma linha principal de extensão da terminação elétrica (5, 6, 7).
Patent BR-PI1106235-B1 (BR)
Title: dispositivo e processo para a navegação orientada de veículos em regiões urbanas e regiões rurais
Inventor: JULIO CEZAR DAVID DE MELO
IPC: G01C21/10
Filed: 2011-12-23
Abstract: DISPOSITIVO E PROCESSO PARA NAVEGAÇÃO ORIENTADA DE VEÍCULOS EM REGIÕES URBANAS E REGIÕES RURAIS. A matéria tratada refere-se a um dispositivo e a um processo de utilização do mesmo que possibilita a identificação da posição de veículos automotores em regiões urbanas e rurais, a partir de uma posição inicial conhecida sem a necessidade do uso de equipamentos receptores do sistema GPS. Essa identificação é feita através da medição da velocidade de deslocamento à posição de repouso do mesmo e da medição da direção de deslocamento do veículo em relação ao campo magnético da Terra; através de sensores destas grandezas e da correlação destas medidas com um mapa digital armazenado na memória do dispositivo.
Patent BR-PI9800337-B1 (BR)
Inventor: CHRISTOPHERSON CINDY DAWN
IPC: C07H21/04
Filed: 1998-01-16
Abstract: The present invention provides improved primers for the polymerase chain reaction (PCR) amplification of a nucleic acid sequence from the gag gene of the human immunodeficiency virus type 1 (HIV-1). The primers and amplification methods of the invention enable the detection of all HIV-1 group M isolates with nearly uniform efficiency.
Patent EA-000515-B1 (EA)
Title: Carbamoyl carboxylic acid amides
Inventor: WETTERICH FRANK
IPC: C07C271/22
Filed: 1996-08-26
Abstract: 1. Carbamoyl carboxylic acid amides of general formula (I)       where R<1> is C1-C8 alkyl, C2-C8-alkenyl or C2-C8-alkinyl, wherein said radicalscan be optianally halogenated and/or can be substituted by one to three groups from the following: cyano, C1-C4 alkoxy, C1-C4-halogenalkoxy, C1-C4-alkylthio, C1-C4 alkoxycarbonyl, C3-C7 cycloalkyl, C3-C7 cycloalkenyl, aryl, aryloxy and Heteroaryl, wherein cyclic and aromatic rings of said groups can contain from one to three subtituents from the following groups: halogen, cyano, C1-C4 alkyl, C1-C4 alkoxyalkyl, C1-C4 halogenalkyl, C1-C4 alkoxy, C1-C4 halogenalkoxy, C1-C4 alkylthio, C1-C4 alkoxycarbonyl, aryl, aryloxy and heteroaryl; R<2> is hydrogen, halogen, cyano, nitro, C1-C8 alkyl, C1-C4 alkoxyalkyl, C1-C4 halogenalkyl, C1-C4 alkoxy, C1-C4 halogenalkoxy, C1-C4 alkylthio, C1-C4 halogenalkylthio or an optionally substituted phenyl group bonded via oxygen or sulphur which can be substituted by one to three substituents from the following: halogen, C1-C4 alkyl and C1-C4 alkoxy, rate of isomer purity exceeds 90 wt %. 2. A process for preparing carbamoyl carboxylic acid amides of general formula (I) as claimed in Claim 1, wherein carbamoyl carboxylic acid of general formula (II)       is subjected to interaction with amine of general formula (III)       3. A process for preparing carbamoyl carboxylic acid amides of general formula (I) as claimed in Claim 1, wherein a) carbamoyl carboxylic acid amides of general formula (I)       in which group R<1>-O-(CO) is a protection group, is transformed in aminoacid amide of formula (IV)       b) thus obtained aminoacid amide of formula (IY)is subjected to interaction with chlorformic acid estereof general formula (V)       in the presence of the base. 4. A preparation against phytopathogenic fungi, containing an effective amount of at least one compound of general formula (I) as claimed in Claim 1 and at least one auxiliary agent. 5. A process for preparing a compound as claimed in Claim 4, wherein fungicide-effective amount of at least one compound of formula (I) as claimed in Claim 1 and at least one auxiliary agent are subjected to a joint treatment. 6. A method of combatting phytopathogenic fungi, wherein fungi, their inhabitant medium, as well as plants, premises, areas or materials needed to be protected against said fungi are to be treated by an effective amount of at least one compound of general formula (I) as claimed in Claim 1 or by a compound as claimed in Claim 4. 7. Use of compounds of general formula (I) as claimed in Claim 1 or preparations as claimed in Claim 4 to combat with phytopathogenic fungi.
Patent EA-002493-B1 (EA)
Title: Liquid waste outlet device
Inventor: MITCHELL GEOFF JOHN
IPC: E03D13/00
Filed: 1998-07-28
Abstract: 1. A urinal bowl waste outlet device including one-way valve means mountable so as to be removable from within the urinal bowl, wherein said one-way valve means does not trap fluid within the device. 2. A device according to claim 1, wherein the one-way valve means is openable to allow the passage of waste fluid from the urinal bowl and closable to block the passage of gas in an upstream direction. 3. A device according to any preceding claim, wherein said one-way valve means opens by means of an automatic reversible deformation in shape. 4. A device according to any preceding claim, including a sheath member for housing the one-way valve means and connectable at an outer portion thereof with the head of a general waste pipe system. 5. A device according to claim 4, including a retaining member for releasably retaining the one-way valve means in place inside the sheath member. 6. A device according to any preceding claim, including an anti-spatter matter. 7. A device according to any preceding claim, including a perfumed or deodorising element. 8. A device according to claim 6, including a perfumed or deodorising element housed substantially within the anti-spatter matter. 9. A urinal bowl waste outlet device/ including: (i) one-way valve means removable from the device; (ii) a sheath member for housing the one-way valve means, wherein said sheath member is designed- at an outer portion to connect with a head of a general waste pipe system of the urinal; and (iii) a retaining member for releasably retaining the one-way valve means in place inside the sheath member. 10. A device according to claim 9, including an anti-spatter member, wherein the retaining member releasably retains the anti-spatter member. 11. A urinal according to claim 9 or 10, wherein the waste outlet device comprises a perfumed or deodorising element. 12. A urinal according to claim 10 or 11, wherein the perfumed or deodorising element is housed substantially within the anti-spatter member. 13. A urinal bowl waste outlet device including one-way valve means mountable so as to be removable from the urinal bowl and a deodorising element. 14. A device according to claim 13, including mounting means for mounting the deodorising element above the one-way valve means. 15. A device according to claim 14, including an anti-spatter member, wherein the mounting means is designed to mount -the anti-spatter member above the one-way valve means with the deodorising element within the anti-spatter member. 16. A urinal fitted with a device according to any preceding claim. 17. A method of operating a urinal equipped with a waste outlet device according to any one of claims 1 to 15 substantially without a continuous or intermittent supply of flushing water. 18. A urinal bowl waste outlet device substantially as described herein with reference to Figs. 2 to 6 of the drawings.
Patent EA-003196-B1 (EA)
Title: Method for delivering an active agent as aerosolized active agent
Inventor: CLARK ANDREW
IPC: A61K9/22
Filed: 1999-03-11
Abstract: 1. A method for delivering an active agent to the lungs of a human patient, comprising delivering an aerosolized active agent formulation at an inspiratory flow rate of less than 17 liters per minute. 2. The method of claim 1 wherein the inspiratory flow rate is less than or equal to 10 liters per minute. 3. The method of claim 1 wherein the aerosolized active agent formulation comprises an active agent in dry powder form. 4. The method of claim 1 wherein the aerosolized active agent formulation comprises an active agent in nebulized form. 5. The method of claim 1 wherein the aerosolized active agent formulation comprises an active agent in admixture with a propellant. 6. The method of claim 1 wherein the aerosolized active agent formulation comprises an active agent solution. 7. The method of claim 1 wherein the aerosolized active agent formulation comprises an active agent suspension. 8. The method of claim 1 wherein the aerosolized active agent formulation comprises an active agent slurry. 9. The method of claim 1 wherein the active agent is selected from the group consisting of cyclosporin, parathyroid hormone, follicle stimulating hormone, alpha-1antitrypsin, budesonide, human growth hormone, growth hormone releasing hormone, interferon alpha, interferon beta, growth colony stimulating factor, leutinizing hormone releasing hormone, calcitonin, low molecular weight heparin, somatostatin, respiratory syncytial virus antibody, erythropoietin, Factor VIII, Factor IX, ceredase, cerezyme and analogues, agonists and antagonists thereof. 10. A method for delivering insulin to the lungs of a human patient, comprising delivering an aerosolized insulin formulation at an inspiratory flow rate less than 17 liters per minute.
Patent EA-007142-B1 (EA)
Title: Copper-base alloy and its use in carburizing environments
Inventor: SZAKALOS PETER
IPC: B01J19/02
Filed: 2003-02-28
Abstract: A copper-base alloy, which is resistant or immune to carburization, metal dusting and cooking, resistant to oxidation and said alloy having the following composition all contents in weight-%: Al >0 - 15 Si >=0 - 6 Mg >=0 - 6. One or more of the group of rare earth Metal REM, yttrium, hafnium, zirconium, lanthanum, cerium up to 0.3 wt. % each Cu balance and normally occurring alloying additions and impurities and use of said alloy as construction components in CO-containing atmospheres, and/or hydrocarbon containing atmospheres or solid carbon containing processes, for example, gasification of solid carbonaceous materials, thermal decomposition of hydrocarbons and catalytic reforming, particularly, catalytic reforming under low-sulfur, and low-sulfur and low-water conditions at temperatures up 1049°C, at least up to 1020°C, at the very least up to 1000°C.
Patent EA-009589-B1 (EA)
Title: Morpholine derivatives for use as dopanine agonists in the treatment of a sexual dysfunction
Inventor: ALLERTON CHARLOTTE MORIA NORFOR
IPC: A61K31/5377
Filed: 2003-12-02
Abstract: The present invention provides for compounds of formula (I), (la) and (lb), wherein: A is selected from C-X and N, B is selected from C-Y and N, Ris selected from H and (C-C)alkyl, Ris selected from H and (C-C)alkyl, X is selected from H, HO, C(O)NH, NH, Y is selected from H HO, NH, Br, Cl and F, Z is selected from H, HO, F, CONHand CN; and pharmaceutically acceptable salts, solvates and prodrugs thereof; with the provisos that: for a compound of formula (I), (la) or (lb), when A is C-X, B is C-Y, at least one of X, Y and Z must be OH; for a compound of formula (I), when A is C-X and B is C-Y, Y is H, Z is H, Ris H and Ris H, then X cannot be OH; these compounds are useful as dopamine agonists for the treatment of i.a. sexual dysfunction.
Patent EA-013368-B1 (EA)
Title: 2,4 (4,6) pyrimidine derivatives
Inventor: FREYNE EDDY JEAN EDGARD
IPC: C07D273/00
Filed: 2005-12-08
Abstract: The present invention concerns the compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Zand Zrepresent NH; Y represents –Calkyl-, -Calkenyl-, -Calkyl-NR-Calkyl-, -Calkyl-NR-CO-Calkyl-, -Calkyl-CO-NH-, -Calkyl-NH-CO-, -Calkyl-CO-Het-CO-, -Calkyl-NH-CO-Het-, -Het-Calkyl-CO-NH-Calkyl-, -Calkyl-NH-CO-L-NH-, -NH-CO-L-NH-, -Calkyl-CO-NH-L-CO-, -Calkyl-NH-CO-L-NH-CO-Calkyl-, -Calkyl-CO-NH-L-CO-NH-Calkyl-, -Calkyl-NR-CH-CO-NH-Calkyl-, Het-CO-Calkyl-, -Calkyl-CO-NH-Calkyl-CO-NH-, -Calkyl-NR-CO-Calkyl-NH-, -Calkyl-NH-CO-Het-CO-, or –Calkyl-CO-Het-CO-NH-; Xrepresents a direct bond, O, -O-Calkyl-, -CO-Calkyl-, -NR-Calkyl-, -CO-NR-, Het-Calkyl- or Calkyl; Xrepresents a direct bond, O, -O-Calkyl-, -CO-Calkyl-, -NR-Calkyl-, -CO-NR-, Het-Calkyl- or Calkyl; Rand Reach independently represent hydrogen, halo, Calkyloxy- or Calkyloxy- substituted with Hetor Calkyloxy-; Rand Reach independently represent hydrogen or halo; Rrepresents hydrogen or cyano; R, R, R, Rand Rrepresent hydrogen; Rrepresents hydrogen or Calkyl; Rand Rrepresent hydrogen, Calkyl or Het-Calkyl-; L, Land Leach independently represents Calkyl optionally substituted with one or where possible two or more substituents selected from phenyl, methylsulfide, cyano, polyhaloCalkyl-phenyl-, Calkyloxy, pyridinyl, mono- or di(Calkyl)-amino- or Ccycloalkyl; Het, Het, Heteach independently represent morpholinyl, oxazolyl, isoxazolyl, or piperazinyl; Het, Het, Heteach independently represent morpholinyl, piperazinyl, piperidinyl or pyrrolidinyl; Hetrepresents piperazinyl, piperidinyl, pyrrolidinyl or azetidinyl; Hetrepresents morpholinyl, oxazolyl, isoxazolyl or piperazinyl wherein said Hetis optionally substituted with Calkyl; Hetand Heteach independently represent a heterocycle selected from pyrrolidinyl, piperazinyl or piperidinyl wherein said Hetor Hetare optionally substituted with Het-carbonyl; Hetand Heteach independently represent a heterocycle selected from morpholinyl, piperazinyl, piperidinyl or pyrrolidinyl.
Patent EA-014249-B1 (EA)
Title: Formulation of extended release levetiracetam
Inventor: KSHIRSAGAR RAJESH
IPC: A61K9/30
Filed: 2005-08-12
Abstract: A pharmaceutical composition of levetiracetam with the extended release with once a day dosage regime and the process of preparing thereof. A tablet of the extended release of levetiracetam with the core comprising of levetiracetam and water dispersible rate controlling polymer, the tablet core optionally functionally coated with a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of psychoneurological side effects by eliminating the troughs and peaks of drug concentration in the patients blood plasma, which comprises administering orally to a patient in need thereof, the tablet of the extended release that provides a peak blood plasma level of levetiracetam in from about eight to about sixteen hours. The core is prepared by wet granulation, dry granulation or direct compression, and optionally the tablet core is coated either in a coating pan or in a fluidized bed system.
Patent EA-022532-B1 (EA)
Title: Power tool cutting apparatus
Inventor: FIRTH ROBERT
IPC: B27G19/04
Filed: 2008-12-01
Abstract: The invention relates to an apparatus for the powered cutting of a workpiece, typically in the form of a planar or sheet material. The apparatus comprises a base (3) onto which a workpiece to be cut can be placed, a guide means including at least first and second slide members (68, 70), mounted at each end thereof at setting clamps (76, 80) fixed to the base (3), a cutting unit (10), fastened on the guide means and comprising a rotable blade (9), a protection device (96) for said blade, drive means (56) for rotating the blade when switching on the apparatus, and a handle unit (66) for holding and moving the cutting unit. The blade is off the guide means, wherein a locking assembly is provided for operating the apparatus in a first mode, at which the locking assembly is released from the guide means and the cutting unit (10) is movable along the guide means, and in a second mode at which the locking assembly interacts with the guide means, thus fixing the cutting unit in the stationary position relative to the guide means. The cutting unit (10) is shifted to one side of said first and second slide members (68, 70) of the slide means, and a slot (6) is made in the base passing parallel to at least one of said at least two spaced slide members (68, 70), wherein the blade is positioned so that at least its lower part enters into said slot (6) and moves along the slot when moving the cutting unit (10) along said at least two slide members. The protection device (96) is adopted to move between the lowered and raised positions. The apparatus is characterised in that the driving edge of the protection device (96) is adopted to rest against the front surface of the workpiece, wherein the driven edge raises upwards for providing its displacement along the upper surface of the workpiece and passing the blade (9) through the workpiece for cutting when moving the cutting unit (10) along the workpiece in the first operation mode or in moving the workpiece relative to the cutting unit in the second operation mode, wherein the protection device (96) jointly with said slot in the base (3), substantially, surrounds the blade and comprises a tightening member to tighten the protection device (96) in the direction of the lowered position providing a touch with the base (3), wherein when the workpiece is positioned between the lower side of said apparatus and the base it resists the tightening member, thus the protection device moves in the raised position, wherein to said at least two slide members (68, 70) a bearing unit is fixed for moving the cutting unit (10) longitudinally parallel to said elements in moving the blade (9) along said slot (6), wherein the blade (9) rotation axis is retained at the constant height relative to the base.
Patent EA-018347-B1 (EA)
Title: Method of manufacturing shaker screen
Inventor: ROBERTSON GRAHAM
IPC: B07B1/28
Filed: 2009-02-04
Abstract: A method of manufacturing a shaker screen is proposed, the method comprising providing a screen frame mold having a neutral axis; positioning reinforcement structure in the screen frame above the neutral axis of the screen frame mold; injecting a material in the screen frame mold to form a screen frame having a neutral axis; removing the screen frame from the mold, wherein the material contracts below the neutral axis of the screen frame, forming frame screen bow.
Patent EA-018566-B1 (EA)
Title: Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer
Inventor: BISINIEKS EGILS
IPC: A61K31/4422
Filed: 2010-03-11
Abstract: New compounds of 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid ester type having general formula (I)wherein R is a lower alkyl group, which is methyl or ethyl, and R1 and R2 is sodium carboxylate-methyl ester, wherein said compounds have synergistic cytotoxic effect combined with 5-fluorouracil.
Patent EA-031063-B1 (EA)
Title: Method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure
Inventor: FRANK MARKUS
IPC: A01N63/22
Filed: 2010-05-03
Abstract: A method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure, wherein the plants, the plant propagules, the seed of the plants and/or the locus where the plants are growing or are intended to grow are treated with an effective amount of a composition comprising: a) the Bacillus subtilis strain with NRRL Accession No. B-21661 or a cell-free extract thereof, and/or a mutant of this strain or extract having all the identifying characteristics of the respective strain or extract as component (I), and b) optionally at least one chemical compound as component (II), selected from the active compound groups A) to J): A) strobilurins; B) carboxamides; C) azoles; D) heterocyclic compounds; E) carbamates; F) other active substances; G) growth regulators; H) herbicides; J) insecticides.
Patent EA-019299-B1 (EA)
Title: Polychromic substances and their use
Inventor: JARVIS ANTHONY
IPC: B41M5/28
Filed: 2009-07-02
Abstract: The invention relates to use of a diacetylene compound as a colour former wherein the diacetylene compound has the following formula (I):wherein one of X and Y is divalent straight-chain or branched alkylene groups, having up to 24 carbon atoms, a divalent phenylene group or a combination of alkylene and phenylene, and the other is a bond or divalent straight-chain or branched alkylene groups, having up to 24 carbon atoms, a divalent phenylene group or a combination of alkylene and phenylene; wherein X and/or Y are substituted with a functional group in the α-position with respect to the diacetylene group; V is a divalent bridging group such as -S-, -O-, -NHR'-, amide, ester, thioester, carbonyl or a carbamate group; wherein R' is hydrogen or alkyl; Q is a divalent bridging group as defined herein; R1 is H or alkyl; and R2 is alkyl. The invention also includes methods of imparting colour to a material including a compound as defined above, which comprises subjecting the material to irradiation.
Patent EA-022029-B1 (EA)
Title: Thienopyrimidinedione derivatives as trpa1 modulators
Inventor: KUMAR SUKEERTHI
IPC: C07D495/04
Filed: 2010-03-23
Abstract: The present invention is related to novel thienopyrimidinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.
Patent EA-023860-B1 (EA)
Title: Negatively biased sealed nebulizers systems and methods
Inventor: BLAKEY DAVID MARK
IPC: A61M11/00
Filed: 2010-07-19
Abstract: Methods, systems, and devices are described for creating a negative bias pressure within a liquid reservoir. Embodiments may include providing a liquid reservoir coupled with an aerosol generator. The liquid reservoir may be sealed to create the sealed reservoir. An ambient pressure may be maintained while the liquid reservoir is being sealed and the ambient pressure may be maintained in the sealed liquid reservoir until a portion of the liquid is dispensed. Further, embodiments may include vibrating the aperture plate to dispense the portion of the liquid. The portion of the liquid dispensed may decreases the amount of the liquid in the sealed reservoir. By decreasing the amount of liquid in the sealed reservoir, a negative bias pressure between an air side and a liquid side of the aperture plate may be created.